News_News_CytoNiche

CDMO of CytoNiche Facilitates Commercialization of Cell Therapy Products | Stem Cell Therapy Products and Services

As cellular drugs are distinct from traditional chemical drugs and biological drugs in terms of process technology, instruments, equipment, and personnel requirements, the CDMO service of cellular dru

31 2022/08

CDMO of CytoNiche Facilitates Commercialization of Cell Therapy Products | Stem Cell Therapy Products and Services

Strategic cooperation | CytoNiche Starts In-depth Cooperation on CDMO Project of Cell Innovation Drugs with Beizheng Stem Cell.

Recently, Beijing CytoNiche Biotechnology Co., Ltd. (hereinafter referred to as CytoNiche) and Jiangxi Beizheng Stem Cell Biotechnology Co., Ltd. (hereinafter referred to as Beizheng Stem Cell) held a strategic cooperation signing ceremony. Through this strategic cooperation, the two parties will make full use of their respective advantages and promote the research and development in the field of large-scale and homogeneous culture of stem cells and clinical application therapy, which is another case for both parties to practice powerful cooperation and innovative development.

30 2022/08

Strategic cooperation | CytoNiche Starts In-depth Cooperation on CDMO Project of Cell Innovation Drugs with Beizheng Stem Cell.

CDMO of CytoNiche Facilitates Commercialization of Cell Therapy Products | Stem Cell Therapy Products and Services

Strategic cooperation | CytoNiche Starts In-depth Cooperation on CDMO Project of Cell Innovation Drugs with Beizheng Stem Cell.

News | CytoNiche Ranked into 36Kr List of Medical Enterprises with 10 Times Growth Potential.

CDMO of CytoNiche Facilitates Commercialization of Cell Therapy Products | Equipment and Consumables for 3D Cell Culture

CytoNiche: New Mode of large-scale Cell Culture CDMO Based on 3D Microcarrier Technology

CDMO of CytoNiche Facilitates Commercialization of Cell Therapy Products | GMP Production Environment of Cells